Keeping Track Of Novel Agents: US FDA Approves Nerlynx And Vosevi, Turns Down Evenity; Macrilen Returns

 
• By Bridget Silverman

News and highlights about novel agents from our FDA Performance Tracker.

Keeping Track Feature image

More from Approvals

More from Product Reviews